It’s politics as usual, but at a cost: the health of the American public. Action Alert!
Month: June 2013
Ag-Gag Bills: Proof Your Activism Brings Results!
The fight isn’t over yet. Some states want to ban filming of factory farm abuses—and fracking operations as well! Action Alerts!
Just Hours Left to Take on the FDA!
Donate before June 21, and we’ll send youan ANH tote bag, a BPA-free Nalgene bottle, ayoga mat, or a picnic blanket. It’s just our way ofsaying “Thanks!” for your support. Make yourtax-deductible donation today! Our supporters never cease to amaze me! I‘ve told you how we must raise $40,000 for several legal petitions to the FDA for… Continue reading Just Hours Left to Take on the FDA!
Congressional Committee to FDA: Listen to ANH-USA and the Supplement Community!
The committee that controls FDA’s purse strings is now turning up the pressure. Will we see change at last? Action Alert!
A Ban on Ginkgo? Even FDA Thinks It’s a Silly Idea
So why has the media been jumping on the bandwagon?
Distressing News: BPA in Mothers May Harm Newborns
It’s time to take the BPA fight to the state legislatures. Action Alerts!
We had to sue the FDA for this info. Act now.
The FDA is censoring speech at the expense of consumers’ health. Enough is enough—it’s time for concrete action. Donate now! Dear Readers: Recently, I asked for your help to raise $40,000: the FDA is shredding free speech to limit supplement access, and we need your support to file legal petitions—the first step to suing the FDA for… Continue reading We had to sue the FDA for this info. Act now.
Is FDA About to Greenlight a Drug Banned in Other Countries?
If enough people raise their voices in protest, we can prevent it. Action Alert!
Danger: Cherry-Picked Drug Studies!
Drug companies are deliberately keeping the public—and the medical community—in the dark about “unfavorable” clinical trials. Action Alert!
If Dr. Offit Had His Way, Vitamins Would Be Treated as Drugs
The New York Times has published another shameful op-ed bashing nutritional supplements. Here’s our response.